Bunnag Thanyanat, Lochindarat Sorasak, Srisan Panida, Jetanachai Pravit
Department of Pediatrics, Queen Sirikit National Institute of Child Health, College of Medicine, Rangsit University, Bangkok, Thailand.
J Med Assoc Thai. 2008 Oct;91 Suppl 3:S124-7.
Mycoplasma pneumoniae is one of the most common causes of childhood community-acquired pneumonia (CAP), particularly in school-age children. Information regarding this infection in pre-school age children is lacking.
To determine the prevalence of M. pneumoniae in young children aged under 5 years with CAP.
This prospective study was conducted at Queen Sirikit National Institute of Child Health (QSNICH), Bangkok, Thailand between December 2001 and November 2002. We enrolled children aged 2 to 5 years with a clinical and radiological diagnosis of CAP. Acute and convalescent sera were collected and measured by using a particle agglutination test. Polymerase chain reaction (PCR) assay for M. pneumoniae was detected from nasopharyngeal secretions. Criteria for diagnosis were defined as > or = 4-found rising of mycoplasma antibody or titer > or = 1:160 with positive PCR.
Thirteen out of 113 CAP patients were diagnosed as mycoplasma pneumonia. Three of them were diagnosed by > or = 4-fold rising of mycoplasma antibody while another 10 patients were diagnosed by mycoplasma titer > or = 1:160 with positive PCR for M. pneumoniae. Clinical symptoms and signs of these 13 mycoplasma pneumonia in young patients were fever (85%), cough (92%), dyspnea (85%), diarrhea (15%), rales (85%), wheezing or rhonchi (46%), and skin rash (15%). Leucocytosis (wbc > 15,000/cumm) was found in 46%. Chest x-rays revealed interstitial infiltration (71%), patchy infiltration (29%) and no pleural effusion was detected. Choices of antibiotic were erythromycin (31%), beta lactam antibiotics (61%), and antibiotic was not prescribed in one patient (8%). Sixty-nine percent of the patients improved, while 31% did not, possibly due to the use of beta lactam antibiotics, or non use of antibiotics.
Mycopalsma pneumonia is not uncommon in children aged 2-5 years with CAP. Clinical signs, symptoms and radiological findings are non-specific and cannot be differentiated from other causes of CAP.
肺炎支原体是儿童社区获得性肺炎(CAP)最常见的病因之一,尤其在学龄儿童中。关于学龄前儿童这种感染的信息尚缺。
确定5岁以下患CAP幼儿中肺炎支原体的患病率。
这项前瞻性研究于2001年12月至2002年11月在泰国曼谷的诗丽吉王后国家儿童健康研究所(QSNICH)进行。我们纳入了临床和影像学诊断为CAP的2至5岁儿童。采集急性期和恢复期血清,采用颗粒凝集试验进行检测。从鼻咽分泌物中检测肺炎支原体的聚合酶链反应(PCR)分析。诊断标准定义为支原体抗体升高≥4倍或滴度≥1:160且PCR阳性。
113例CAP患者中有13例被诊断为支原体肺炎。其中3例通过支原体抗体升高≥4倍确诊,另外10例通过支原体滴度≥1:160且肺炎支原体PCR阳性确诊。这13例幼儿支原体肺炎的临床症状和体征包括发热(85%)、咳嗽(92%)、呼吸困难(85%)、腹泻(15%)、啰音(85%)、喘息或哮鸣音(46%)以及皮疹(15%)。46%的患者白细胞增多(白细胞>15,000/立方毫米)。胸部X线显示间质浸润(71%)、斑片状浸润(29%),未检测到胸腔积液。抗生素选择为红霉素(31%)、β-内酰胺类抗生素(61%),1例患者未使用抗生素(8%)。69%的患者病情好转,31%的患者未好转,可能是由于使用了β-内酰胺类抗生素或未使用抗生素。
2至5岁患CAP的儿童中支原体肺炎并不少见。临床症状、体征和影像学表现无特异性,无法与其他CAP病因相鉴别。